NEEDHAM, Mass.--(BUSINESS WIRE)-- Celldex Therapeutics, Inc. (NASDAQ: CLDX) today announced that Ronald A. Pepin, Ph.D., Senior Vice President and Chief Business Officer of Celldex Therapeutics, Inc., will participate with other deal experts in a panel discussion moderated by Karen Bernstein, Co-Founder, Chairman and Editor-in-Chief of BioCentury, at the 17th Annual BIO-Europe® 2011 Biotechnology Partnering Conference on Monday, October 31, 2011, in Duesseldorf, Germany.
